Viscera Technologies is Diagnostic Equipment in United Kingdom that focus on flow IVD business. Founded in 2018. They cover business area such as developer, manufacturer, lateral flow IVD (in vitro diagnostic) device, H. Pylori infection, capability, preventative diagnosis, care, medical practitioner, global demographic, incredible accuracy, patient, an early stage, low cost.
2018
( 8 years old in 2026 )
Flow IVD
-
64 New Cavendish Street
London W1G 8TB
England, United Kingdom
Private
developermanufacturerlateral flow IVD (in vitro diagnostic) deviceH. Pylori infectioncapabilitypreventative diagnosiscaremedical practitionerglobal demographicincredible accuracypatientan early stagelow cost
* We use standard office opening hours in near Viscera Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Viscera Technologies is Diagnostic Equipment business from United Kingdom that founded in 2018 (8 years old in 2026), Viscera Technologies business is focusing on Flow IVD.
Viscera Technologies headquarter office and corporate office address is located in 64 New Cavendish Street London W1G 8TB England, United Kingdom.
Viscera Technologies was founded in United Kingdom.
In 2026, Viscera Technologies is currently focus on flow IVD sector.
Above is snippet of Google Trends for "flow IVD" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Viscera Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.